No Detail Found!

Role of Alpha-methylacyl-CoA Racemase Gene in Pathogenicity of CMT Patients.

Author(s)
Sumaira Kanwal Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal Campus, Pakistan
Shazia Perveen Department of Zoology, The Women University, Multan, Pakistan
Hafiz Muhammad Arshad Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal Campus, Pakistan
Abstract
Objective: To find the causative mutation by linkage analysisof Charcot-Marie-Tooth disease while focussing on AMACR gene. Methods: The case-control study was conducted from November 2016 to March 2017 in Kongju National University Korea. A family of 15 members with composite symptoms of peripheral neuropathy were enrolled. In addition, 50 healthy controls, which had no clinical features and family history of neuromuscular disorders, were also recruited. The family was selected for sequencing analysis by using capillary sequencing. It was sequenced for all the causative genes for CMT disease i.e. PMP22, MPZ, MFN2, GDAP1, NEFL, CX32, MYH14, LMNA, TRPV4, LITAF. Various regions of chromosome were suspected based on the logarithm of the odds score. Results: Of the 15-member family, 7(47%) were affected and 8(53%)were unaffected. Those unaffected also acted as the controls. A missense mutation was found in exon 1 of the AMACR gene at p.Gly175Asp position. The mutation was also found in some of the unaffected members as well as in the control samples. Conclusion: As the mutation was found in the healthy samples as well, it can be said that the current mutation AMACR can be involved in some other forms of peripheral neuropathy which can be with other phenotypes.
Publication Details
Page(s) 1039-1042
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 7, Year: 2018

Request the full text from PASTIC

References
CuebasDA,PhillipsC,SchmitzW,ConzelmannE,NovikovDK, 2002.The role of alpha-methylacyl-CoA racemase in bile acid synthesis,Biochem J 363 801 -7
FogelBL,PerlmanS., 2006.An approach to the patient with late-onset cerebellar ataxia. Nature clinical practice,Nat Clin Pract Neurol 2 629 -35
BespalovaIN,DurnerM,RitterBP,AngeloGW,Rossy-FullanaE,Carrion-BaraltJ, 2010.Non-synonymous variants in the AMACR gene are associated with schizophrenia,Schizophr Res 124 208 -15
SavolainenK,KottiTJ,SchmitzW,SavolainenTI,SormunenRT,IlvesM, 2004.A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids,Hum Mol Genet 13 955 -65
FerdinandusseS,DenisS,ClaytonPT,GrahamA,ReesJE,AllenJT, 2000.Mutations in the gene encoding peroxisomal [alpha]- methylacyl-CoA racemase cause adult-onset sensory motor neuropathy,Nat Genet 24 188 -91
OuyangB,LeungYK,WangV,ChungE,LevinL,BrackenB, 2011.- Methylacyl-CoA Racemase Spliced Variants and Their Expression in Normal and Malignant Prostate Tissues, 77 1 -7
Van VeldhovenPP,CroesK,CasteelsM,MannaertsGP, 1997.- Methylacyl racemase: a coupled assay based on the use of pristanoyl-CoA oxidase/peroxidase and reinvestigation of its subcellular distribution in rat and human liver,Biochim Biophys Acta 1347 62 -8
StojkovicT., 2016.Hereditary neuropathies: An update,Revue neurologique 172 775 -8
HardingAE,ThomasPK., 1980.The clinical features of hereditary motor and sensory neuropathy types I and II, 103 259 -80
TimmermanV,StricklandAV,ZüchnerS, 2014.Genetics of CharcotMarie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success,Genes (Basel) 5 13 -32
GessB,SchirmacherA,YoungP, 2013.Genetics of neuropathies,Der Nervenarzt 84 157 -65
Lacour A, 2013.Current issues in hereditary neuropathies,Revue neurologique 169 1001 -3
NidhiShukla,JaysreeRath,- Coenzyme A, 2017.Racemase (AMACR) in Colorectal Neoplasia,J Clin Diagn Res 11 EC35 -8
VallatJM,MathisS,FunalotB., 2013.The various Charcot-Marie-Tooth diseases,Curr Opin Neurol 26 473 -80
Dubourg O., 2012.Developments in hereditary neuropathies,Revue neurologique 168 983 -5
ChongCM,AiN,LeeSM, 2017.ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders,Curr Drug Targets 18 455 -62
WuBQ,BiZG,QiQ., 2013.Inactivation of the Rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats,Chin Med J (Engl) 126 3723 -7
0

Citations

0

Downloads

48

Views